Finding:

1. close

   Breast cancer treatment

   It treats only the area where the tumor was surgically removed, plus adjacent tissue. ... Physical examination and conventional imaging techniques still have an important place in the evaluation of breast cancer treated by neoadjuvant chemotherapy.
2. close

   Chemotherapy

   Chemotherapy, in its most general sense, is the treatment of disease by chemicals especially by killing micro-organisms or cancerous cells. In popular usage, it refers to antineoplastic drugs used to treat cancer or the combination of these drugs into a cytotoxic standardized treatment regimen.
3. close

   Post-chemotherapy cognitive impairment

   Post-chemotherapy cognitive impairment (PCCI) (also known as chemotherapy-induced cognitive dysfunction, chemo brain or chemo fog) describes the cognitive impairment that can result from chemotherapy treatment. ... "Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients--evaluation of appropriate research design and methodology to measure symptoms".
4. close

   Chemotherapy-induced neutropenia

   Chemotherapy-induced neutropenia is a condition characterized by abnormally low blood levels of infection-fighting neutrophils, a specific kind of white blood cell. The most common reason that cancer patients experience neutropenia is as a side effect of chemotherapy.
5. close

   Adjuvant chemotherapy

   Adjuvant therapy is a term used to describe the role of therapy relative to other cancer treatments. ... combination adjuvant chemotherapy for breast cancer
6. close

   Merck & Co.

   Merck & Co., Inc. (NYSE: MRK), also known as Merck Sharp & Dohme or MSD outside the United States and Canada, is one of the largest pharmaceutical companies in the world. ... Emend (aprepitant) – treats vomiting and nausea brought about by chemotherapy.
7. close

   Lymphoma in animals

   Lymphoma in animals is a type of cancer defined by a proliferation of malignant lymphocytes within solid organs such as the lymph nodes, bone marrow, liver and spleen. ... [Expression error: Missing operand for > "Evaluation of an actinomycin-D-containing combination chemotherapy protocol with extended maintenance therapy for canine lymphoma"].
8. close

   History of cancer chemotherapy

   The era of cancer chemotherapy began in the 1940s with the first use of nitrogen mustards and folic acid antagonist drugs. Cancer drug development has exploded since then into a multi-billion dollar industry.
9. close

   Mapatumumab

   Mapatumumab (HGS-ETR1) is a human monoclonal antibody used in the treatment of cancer. ... These results supported further evaluation of HGS-ETR1 in combination with chemotherapy in phase 2 trials.
10. close

    Ridaforolimus

    Ridaforolimus (also known as AP23573 and MK-8669; formerly known as Deforolimus) is an immunosuppressant currently undergoing research for the treatment of certain cancers. ... As of 2008, a phase III clinical trial of ridaforolimus in metastatic soft-tissue and bone sarcomas responsive to chemotherapy, SUCCEED (Sarcoma Multi-Center Clinical Evaluation of the Efficacy of Deforolimus), is recruiting patients.

Explore the following pages on Powerset:

• Breast cancer treatment,
• Chemotherapy,
• Post-chemotherapy cognitive impairment,
• Chemotherapy-induced neutropenia,
• Adjuvant chemotherapy,
• Merck & Co.,
• Lymphoma in animals,
• History of cancer chemotherapy,
• Mapatumumab,
• Ridaforolimus

Try this on Bing Research

Bing